Takeyuki Shimizu

Takeyuki Shimizu

Auto-generated profile, based on publicly available information

Takeyuki Shimizu

Department of Immunology, Kochi Medical School Kochi University Nankoku‐shi Kochi Japan

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2005 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
KOKazuo Ohnishi
Kazuo Ohnishi
FMFritz Melchers
Fritz Melchers
TSTakeyuki Shimizu
Takeyuki Shimizu
The gene encoding BILL‐cadherin/cadherin‐17, a nonclassical cadherin expressed on B lymphocytes in a stage‐and‐site‐specific manner, was inactivated by targeted disruption of its transmembrane/cytoplasmic portion‐encoding parts. BILL‐cadherin deficiency caused a threefold proB cell accumulation, as well as a reduction to half of the numbers of immature B cells in bone marrow. In spleen, CD21hiCD23lo marginal zone B cells were found reduced and the structure of the marginal zone was impaired. In addition, the size and number of germinal center as well as the number of PNA+ cells were significantly reduced in BILL‐cadherin‐deficient mice. In the peritoneal cavity of mutant mice IgM+Mac‐1+CD5+ B1a cell, that express high BILL‐cadherin in wild‐type mice, was also reduced in number. The IgG1 and IgG3 antibody response to the T‐independent antigen, TNP‐Ficoll, was impaired in the mutant mice. These results indicate that BILL‐cadherin participates in B lymphocyte development at least at two stages, first at the transition of pro/preB‐I cells to preB‐II cells possibly in association with surrogate light chain in bone marrow, and later at the point of development, accumulation and reactiveness of immature B cells in spleen.

1 November 1995 in Journal of Virology
Verified
Journal Article
Open access
TKT Kondo
T Kondo
Hirohide UenishiHirohide Uenishi
Hirohide Uenishi
TST Shimizu
T Shimizu
THT Hirama
T Hirama
MIM Iwashiro
M Iwashiro
MMMasaaki Miyazawa
Masaaki Miyazawa
Several dominant T-cell receptors of cytotoxic T-lymphocyte (CTL) clones specific for FBL-3 tumor antigen were clonally amplified in mixed lymphocyte tumor cell cultures derived from an individual immune mouse. Every CTL clone analyzed had a common specificity for a single epitope in the precursor to cell membrane-associated nonstructural gag-encoded protein, Pr75gag, which can be minimally identified by nine amino acid residues, SIVLCCLCL. This epitope is located within the hydrophobic signal sequence motif that mediates translocation of the protein into the endoplasmic reticulum. These novel observations suggest that expression of Pr75gag in FBL-3 tumor cells led to the amplification of CTLs which recognize the signal sequence of the nonstructural gag-encoded glycoprotein precursor.

20 September 2023 in Protein Science
Verified
Journal Article
Closed access
GBGert-Jan Bekker
Gert-Jan Bekker
NNNobutaka Numoto
Nobutaka Numoto
MKMaki Kawasaki
Maki Kawasaki
THTakahiro Hayashi
Takahiro Hayashi
SYSaaya Yabuno
Saaya Yabuno
NKNarutoshi Kamiya
Narutoshi Kamiya

28 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YTYasuyuki Tashiro
Yasuyuki Tashiro
AMAkikazu Murakami
Akikazu Murakami
YHYasushi Hara
Yasushi Hara
TSTakeyuki Shimizu
Takeyuki Shimizu
MKMasato Kubo
Masato Kubo
TATakachika Azuma
Takachika Azuma
IgM antibodies (Abs) are thought to play a major role in humoral immunity but only at the early stage of the primary immune response. However, two subsets of IgM+ memory B cells (MBCs), one with high affinity gained by means of multiple somatic hypermutation (SHM) and the other with low affinity and no SHMs, are generated through the germinal center (GC)-dependent and GC-independent (non-GC) pathway, respectively, after immunization with (4-hydroxy-3-nitrophenyl)acetyl (NP)-chicken γ-globulin. Surprisingly, an analysis of antibody-secreting cells reveals that a large amount of anti-NP IgM Ab with few SHMs is secreted during the recall response, indicating that only non-GC MBCs have terminal differentiation potential. Since secondary IgM Abs are capable of binding to dinitrophenyl ligands, they likely provide broad cross-reactivity in defense against microbial infection.